Gatti, M.; Rinaldi, M.; Tonetti, T.; Siniscalchi, A.; Viale, P.; Pea, F.
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration. Antibiotics 2023, 12, 1524.
https://doi.org/10.3390/antibiotics12101524
AMA Style
Gatti M, Rinaldi M, Tonetti T, Siniscalchi A, Viale P, Pea F.
Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration. Antibiotics. 2023; 12(10):1524.
https://doi.org/10.3390/antibiotics12101524
Chicago/Turabian Style
Gatti, Milo, Matteo Rinaldi, Tommaso Tonetti, Antonio Siniscalchi, Pierluigi Viale, and Federico Pea.
2023. "Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration" Antibiotics 12, no. 10: 1524.
https://doi.org/10.3390/antibiotics12101524
APA Style
Gatti, M., Rinaldi, M., Tonetti, T., Siniscalchi, A., Viale, P., & Pea, F.
(2023). Real-Time TDM-Based Expert Clinical Pharmacological Advice Program for Attaining Aggressive Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Meropenem in the Treatment of Critically Ill Patients with Documented Gram-Negative Infections Undergoing Continuous Veno-Venous Hemodiafiltration. Antibiotics, 12(10), 1524.
https://doi.org/10.3390/antibiotics12101524
